A fa­vorite in Alex­ion’s C-suite is leav­ing, and some mighty sur­prised an­a­lysts aren’t the least bit hap­py about it

An­a­lysts hate to lose a biotech CFO they’ve come to trust and ad­mire — es­pe­cial­ly if they’re be­ing blind­sided by a sur­prise ex­it.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.